NDC 17772-133

QELBREE

Viloxazine Hydrochloride

QELBREE is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Supernus Pharmaceuticals, Inc. The primary component is Viloxazine Hydrochloride.

• Product ID: 17772-133_bfca3279-8f36-5bb2-e053-2995a90a23a5
• NDC: 17772-133
• Product Type: Human Prescription Drug
• Proprietary Name: QELBREE
• Generic Name: Viloxazine Hydrochloride
• Dosage Form: Capsule, Extended Release
• Route of Administration: ORAL
• Marketing Start Date: 2021-04-02
• Marketing Category: NDA /
• Application Number: NDA211964
• Labeler Name: Supernus Pharmaceuticals, Inc
• Substance Name: VILOXAZINE HYDROCHLORIDE
• Active Ingredient Strength: 200 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 17772-133-01

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-01)

• Marketing Start Date: 2021-04-02
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "QELBREE" or generic name "Viloxazine Hydrochloride"

NDC	Brand Name	Generic Name
17772-131	QELBREE	viloxazine hydrochloride
17772-132	QELBREE	viloxazine hydrochloride
17772-133	QELBREE	viloxazine hydrochloride